Cardiac Dimensions, a medical device company based in Kirkland, Wash., landed $35 million to support testing and marketing of its system to treat mitral valve regurgitation. Mitral valve regurgitation ...
KIRKLAND, Wash. -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today ...
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions ...
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, a leader in the development of innovative and minimally invasive treatment modalities to address patients suffering from heart failure with ...
KIRKLAND, Wash., Aug. 20, 2021 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related ...
Hosted on MSN
Cardiac Dimensions secures $53M for heart device
Greetings Kirkland! Your go-to source for what's happening in town is here. Stay in the loop and read on. ☕️️ In today's newsletter: Cardiac Dimensions secures $53M for heart device Federal Way ...
Prominent heart failure cardiologist Dr. William Abraham to play pivotal role in the advancement of the Carillon Mitral Contour System® to heart failure patients with FMR. Cardiac Dimensions®, a ...
Ahead of the Transcatheter Cardiovascular Therapeutics (TCT) 2018 conference, Kirkland, Wash.-based Cardiac Dimensions Inc. reported the randomization of the first patient in the CARILLON pivotal ...
Kirkland, Wash.-based Cardiac Dimensions raised a $17.5 million Series C round. The company will use the fresh cash to help sell its heart-valve repair device. Founded in 2001, the Seattle-area ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback